These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29251012)

  • 1. Enhancing Effect of Hydroxyurea on Hb F in Sickle Cell Disease: Ten-Year Egyptian Experience.
    Youssry I; Abdel-Salam A; Ismail R; Bou-Fakhredin R; Mohamed Samy R; Ezz El-Deen F; Taher AT
    Hemoglobin; 2017; 41(4-6):267-273. PubMed ID: 29251012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
    el-Hazmi MA; al-Momen A; Warsy AS; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F
    Acta Haematol; 1995; 93(2-4):57-61. PubMed ID: 7543719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease.
    de Montalembert M; Belloy M; Bernaudin F; Gouraud F; Capdeville R; Mardini R; Philippe N; Jais JP; Bardakdjian J; Ducrocq R; Maier-Redelsperger M; Elion J; Labie D; Girot R
    J Pediatr Hematol Oncol; 1997; 19(4):313-8. PubMed ID: 9256830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease.
    Jain DL; Sarathi V; Desai S; Bhatnagar M; Lodha A
    Hemoglobin; 2012; 36(4):323-32. PubMed ID: 22734586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose hydroxyurea is effective in reducing the incidence of painful crisis and frequency of blood transfusion in sickle cell anemia patients from eastern India.
    Patel DK; Mashon RS; Patel S; Das BS; Purohit P; Bishwal SC
    Hemoglobin; 2012; 36(5):409-20. PubMed ID: 22881992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal doses of hydroxyurea for sickle cell disease.
    Lima CS; Arruda VR; Costa FF; Saad ST
    Braz J Med Biol Res; 1997 Aug; 30(8):933-40. PubMed ID: 9361721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
    Borba R; Lima CS; Grotto HZ
    J Clin Lab Anal; 2003; 17(2):66-72. PubMed ID: 12640630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal hemoglobin response to hydroxyurea in Yemeni sickle cell disease patients.
    Al-Nood HA; Al-Khawlani MM; Al-Akwa A
    Hemoglobin; 2011; 35(1):13-21. PubMed ID: 21250877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.
    Koren A; Segal-Kupershmit D; Zalman L; Levin C; Abu Hana M; Palmor H; Luder A; Attias D
    Pediatr Hematol Oncol; 1999; 16(3):221-32. PubMed ID: 10326220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea in the treatment of sickle-cell anemia.
    Howard LW; Kennedy LD
    Ann Pharmacother; 1997 Nov; 31(11):1393-6. PubMed ID: 9391697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea and erythropoietin therapy in sickle cell anemia.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Lacroix L; Bunn HF
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):74-81. PubMed ID: 1379376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease.
    Maier-Redelsperger M; de Montalembert M; Flahault A; Neonato MG; Ducrocq R; Masson MP; Girot R; Elion J
    Blood; 1998 Jun; 91(12):4472-9. PubMed ID: 9616141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory effects of hydroxyurea in children and adolescents with sickle cell anemia: a Portuguese hospital study.
    Braga LB; Ferreira AC; Guimarães M; Nazário C; Pacheco P; Miranda A; Picanço I; Seixas T; Rosado L; Amaral JM
    Hemoglobin; 2005; 29(3):171-80. PubMed ID: 16114180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea use in young infants with sickle cell disease.
    Schuchard SB; Lissick JR; Nickel A; Watson D; Moquist KL; Blaylark RM; Nelson SC
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27650. PubMed ID: 30729675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia.
    Orringer EP; Blythe DS; Johnson AE; Phillips G; Dover GJ; Parker JC
    Blood; 1991 Jul; 78(1):212-6. PubMed ID: 1712641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pharmacological efficacy and safety of hydroxyurea in sickle cell disease: Study of a pediatric cohort from Chhattisgarh, India.
    Lad H; Naskar S; Punyasri Pasupuleti SKDB; Nahrel R; Sihare P; Chandak GR; Patra PK
    Pediatr Hematol Oncol; 2023 May; 40(4):395-406. PubMed ID: 36226857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Hydroxyurea use in children with sickle cell disease: low dose regimen is effective.
    Sharef SW; Al-Hajri M; Beshlawi I; Al-Shahrabally A; Elshinawy M; Zachariah M; Mevada ST; Bashir W; Rawas A; Taqi A; Al-Lamki Z; Wali Y
    Eur J Haematol; 2013 Jun; 90(6):519-24. PubMed ID: 23489171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and urine hydroxyurea levels might be useful in the management of adult sickle cell disease.
    Bachir D; Hulin A; Huet E; Habibi A; Nzouakou R; El Mahrab M; Astier A; Galacteros F
    Hemoglobin; 2007; 31(4):417-25. PubMed ID: 17994375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia.
    Jayabose S; Tugal O; Sandoval C; Patel P; Puder D; Lin T; Visintainer P
    J Pediatr; 1996 Oct; 129(4):559-65. PubMed ID: 8859263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.